NSE IPO GMP Falls Below ₹50 as Subscription Deadline Ends Today
The grey‑market premium (GMP) for the National Stock Exchange (NSE) initial public offering has slipped below ₹50, marking the final day for investors to place bids. The IPO, which was fully subscribed within two days, is now approaching its scheduled listing on 24 September.
Current GMP Situation
Market data shows the GMP hovering just under the ₹50 mark, a noticeable decline from earlier levels where the premium briefly exceeded ₹300. This drop suggests a modest listing gain of around three percent, according to recent investor reports.
Grey‑Market Activity
Investors tracking the grey market note that the NSE IPO is trading at a premium of ₹48 today. While the premium remains positive, the rapid fall in GMP over the past few days has raised concerns among some participants.
IPO Timeline and Pricing
The retail tranche of the NSE IPO opened on 17 September, giving investors until 21 September – today – to submit applications. The issue price band was set between ₹1,700 and ₹1,785 per share, with a lot size of eight shares, meaning a minimum investment of ₹14,280. Employees of the company were offered a discount of ₹170 per share.
Subscription Overview
Overall, the offering size totals ₹22,561.57 crore, with 12.64 crore shares to be issued on an offer‑for‑sale (OFS) basis. Retail investors subscribed to 0.69 % of the allocation, qualified institutional buyers (QIBs) took up 1.32 times the issue, and non‑institutional investors (NIIs) applied for 1.46 times. In total, the IPO was subscribed at 1.04 times during the first two days.
Investor Sentiment
Recent activity indicates that selling pressure is coming mainly from existing investors rather than new demand. Despite the falling GMP, the IPO achieved 100 % subscription within the allotted period, suggesting strong underlying interest.
Listing Plans
The NSE shares are slated to list on the Bombay Stock Exchange (BSE) on 24 September, pending regulatory approvals.
Investors should remember that this article does not constitute investment advice. Stock market investments carry risk, and professional guidance is recommended before making any decisions.
